Skip to content

NEOS THERAPEUTICS, INC.

CIK 0001467652

← back to feed
Revenue (TTM)
$57.7M
−4.0% YoY Q3 Nov 2020
Net Income (TTM)
−$20.42M
+67.3% YoY Q3 Nov 2020
EPS Diluted (TTM)
—
Q3 Nov 2020
Gross Margin
58.7%
Q3 Nov 2020
Operating Margin
-21.0%
Q3 Nov 2020
Net Margin
-35.4%
Q3 Nov 2020
Free Cash Flow (TTM)
−$36.56M
Q3 Nov 2020
Cash
$12.74M
Q3 Nov 2020
Total Debt
—
Q3 Nov 2020
Shares Outstanding
49.76M sh
Q3 Nov 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings